Headlines

Research & Studies

Proteomics International clinches EU patent for 'breakthrough' kidney disease test

Proteomics International clinches EU patent for 'breakthrough' kidney disease test

Proteomics International (ASX: PIQ) has cemented its commercial ownership rights in Europe for its “breakthrough” diabetic kidney disease prediction test through to 2031, after securing a patent for the region. Securing the European patent adds ...